CH5.L vs. LHTC.DE
Compare and contrast key facts about Amundi ETF MSCI Europe Healthcare UCITS ETF (CH5.L) and Lyxor STOXX Europe 600 Healthcare UCITS ETF Acc (LHTC.DE).
CH5.L and LHTC.DE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. CH5.L is a passively managed fund by Amundi that tracks the performance of the MSCI World/Health Care NR USD. It was launched on Dec 4, 2008. LHTC.DE is a passively managed fund by Amundi that tracks the performance of the STOXX® Europe 600 Health Care. It was launched on Aug 18, 2006. Both CH5.L and LHTC.DE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CH5.L or LHTC.DE.
Key characteristics
| CH5.L | LHTC.DE | |
|---|---|---|
| YTD Return | 11.27% | 12.68% |
| 1Y Return | 7.82% | 9.27% |
| 3Y Return (Ann) | 11.33% | 10.53% |
| 5Y Return (Ann) | 10.84% | 10.86% |
| 10Y Return (Ann) | 8.47% | 8.76% |
| Sharpe Ratio | 0.56 | 0.65 |
| Daily Std Dev | 13.86% | 13.24% |
| Max Drawdown | -19.44% | -40.53% |
| Current Drawdown | 0.00% | 0.00% |
Correlation
The correlation between CH5.L and LHTC.DE is 0.79, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
CH5.L vs. LHTC.DE - Performance Comparison
In the year-to-date period, CH5.L achieves a 11.27% return, which is significantly lower than LHTC.DE's 12.68% return. Both investments have delivered pretty close results over the past 10 years, with CH5.L having a 8.47% annualized return and LHTC.DE not far ahead at 8.76%. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
CH5.L vs. LHTC.DE - Expense Ratio Comparison
CH5.L has a 0.25% expense ratio, which is lower than LHTC.DE's 0.30% expense ratio.
Risk-Adjusted Performance
CH5.L vs. LHTC.DE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Amundi ETF MSCI Europe Healthcare UCITS ETF (CH5.L) and Lyxor STOXX Europe 600 Healthcare UCITS ETF Acc (LHTC.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CH5.L vs. LHTC.DE - Dividend Comparison
Neither CH5.L nor LHTC.DE has paid dividends to shareholders.
Drawdowns
CH5.L vs. LHTC.DE - Drawdown Comparison
The maximum CH5.L drawdown since its inception was -19.44%, smaller than the maximum LHTC.DE drawdown of -40.53%. Use the drawdown chart below to compare losses from any high point for CH5.L and LHTC.DE. For additional features, visit the drawdowns tool.
Volatility
CH5.L vs. LHTC.DE - Volatility Comparison
The current volatility for Amundi ETF MSCI Europe Healthcare UCITS ETF (CH5.L) is 2.98%, while Lyxor STOXX Europe 600 Healthcare UCITS ETF Acc (LHTC.DE) has a volatility of 3.33%. This indicates that CH5.L experiences smaller price fluctuations and is considered to be less risky than LHTC.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.